Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

May your holidays be filled with joy, love and happiness!

Page View:

At the end of 2021, let’s think back and catch up! We’d like to thank you for this splendid and fruitful year. 

Here’s what we’ve accomplished in 2021:

In 2021, 76 projects that Medicilon participated in gained the approval of clinical trials successfully.

Among the 76 projects that were approved, 17 projects succeeded in FDA filing and NMPA/FDA. Medicilon was dedicated in establishing the integrated international R&D services that enabled clients to reach their goals of filing in registration institutions worldwide.

We occupy over 800,000 sq. ft. of lab space (dry labs and wet labs included), with a full range of lab equipment ready to conquer the most challenging R&D projects!

Medicilon family now consists of more than 2,400 scientists and support staff, of which all are committed to helping clients find innovative solutions with high efficiency and quality.


Relevant newsRelevant news